{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:47:42Z","timestamp":1784116062185,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clineuro.2020.106377","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:35:34Z","timestamp":1605616534000},"page":"106377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2\u2032-deoxyguanosine in patients with multiple sclerosis"],"prefix":"10.1016","volume":"200","author":[{"given":"Negin Bodaghi","family":"Khajenobar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soltanali","family":"Mahboob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-1335","authenticated-orcid":false,"given":"Alireza","family":"Nourazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2663-723X","authenticated-orcid":false,"given":"Behrouz","family":"Shademan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delara","family":"Laghousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre Bagheri","family":"Moayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Nikanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.clineuro.2020.106377_bib0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000360528","article-title":"Multiple sclerosis: current knowledge and future outlook","volume":"72","author":"Kamm","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.clineuro.2020.106377_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jocn.2020.04.071","article-title":"Investigation the miRNA146a and miRNA155 gene expression levels in patients with multiple sclerosis","volume":"78","author":"Shademan","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.clineuro.2020.106377_bib0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.apjtb.2016.03.009","article-title":"Multiple sclerosis: new insights and trends","volume":"6","author":"Koriem","year":"2016","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.clineuro.2020.106377_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fnana.2019.00095","article-title":"Th17 and cognitive impairment: possible mechanisms of action","volume":"13","author":"Cipollini","year":"2019","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.clineuro.2020.106377_bib0025","first-page":"19","article-title":"Biomarkers of multiple sclerosis: current findings","volume":"7","author":"Harris","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.clineuro.2020.106377_bib0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2217\/nmt.15.50","article-title":"Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology","volume":"5","author":"Lee","year":"2015","journal-title":"Neurodegener. Dis. Manag."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms13584","article-title":"Structural basis of myelin-associated glycoprotein adhesion and signalling","volume":"7","author":"Pronker","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clineuro.2020.106377_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2015.00051","article-title":"MAG, myelin and overcoming growth inhibition in the CNS","volume":"8","author":"McKerracher","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.clineuro.2020.106377_bib0050","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/ijms21124229","article-title":"Molecular effects of FDA-approved multiple sclerosis drugs on glial cells and neurons of the central nervous system","volume":"21","author":"De Kleijn","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106377_bib0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020602","article-title":"Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia","volume":"7","author":"Silver","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.clineuro.2020.106377_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3164734","article-title":"The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults","volume":"2016","author":"Nita","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/molecules25010202","article-title":"8-Oxo-7, 8-dihydro-2\u2032-deoxyguanosine (8-oxodG) and 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) as a potential biomarker for gestational diabetes mellitus (GDM) development","volume":"25","author":"Urbaniak","year":"2020","journal-title":"Molecules."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106377_bib0070","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.151.4.2132","article-title":"Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide","volume":"151","author":"Merrill","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.clineuro.2020.106377_bib0075","first-page":"1","article-title":"Antioxidants and antioxidant methods: an updated overview","author":"Gulcin","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-016-0792-7","article-title":"Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update","volume":"12","author":"Rubio","year":"2016","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.clineuro.2020.106377_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.02.003","article-title":"The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis","volume":"127","author":"Mallucci","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106377_bib0090","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2020.106377_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1973834","article-title":"New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis","volume":"2016","author":"Adamczyk","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0100","doi-asserted-by":"crossref","DOI":"10.2174\/1874226201909010001","article-title":"Biomarkers of multiple sclerosis","volume":"9","author":"Pastare","year":"2019","journal-title":"Open Immunol. J."},{"key":"10.1016\/j.clineuro.2020.106377_bib0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/B978-0-12-370491-7.00026-X","article-title":"Cerebrospinal fluid","author":"Vernau","year":"2008","journal-title":"Clin. Biochem. Domest. Anim."},{"key":"10.1016\/j.clineuro.2020.106377_bib0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuint.2019.04.015","article-title":"Sampling issues of cerebrospinal fluid and plasma monoamines: investigation of the circadian rhythm and rostrocaudal concentration gradient","volume":"128","author":"Janssens","year":"2019","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0115","doi-asserted-by":"crossref","DOI":"10.2174\/1874226201909010001","article-title":"Biomarkers of multiple sclerosis","volume":"9","author":"Pastare","year":"2019","journal-title":"Open Immunol. J."},{"issue":"11","key":"10.1016\/j.clineuro.2020.106377_bib0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1756283X17731520","article-title":"Insights into the management of Wilson\u2019s disease","volume":"10","author":"Kathawala","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"2","key":"10.1016\/j.clineuro.2020.106377_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.33176\/AACB-18-00014","article-title":"Biochemical markers for the diagnosis and monitoring of Wilson disease","volume":"40","author":"Mohr","year":"2019","journal-title":"Clin. Biochem. Rev."},{"issue":"23","key":"10.1016\/j.clineuro.2020.106377_bib0130","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms13584","article-title":"Structural basis of myelin-associated glycoprotein adhesion and signalling","volume":"7","author":"Pronker","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.clineuro.2020.106377_bib0140","article-title":"Acute autonomic symptoms with anti-myelin-associated glycoprotein neuropathy as a presentation of small B cell lymphoma: a case report and literature review","volume":"10","author":"Jahngir","year":"2018","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.clineuro.2020.106377_bib0145","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1471-4159.2006.04319.x","article-title":"Myelin\u2010associated glycoprotein (MAG): past, present and beyond","volume":"100","author":"Quarles","year":"2007","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.clineuro.2020.106377_bib0150","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/jcm8111815","article-title":"Oxidative stress and inflammation interdependence in multiple sclerosis","volume":"8","author":"Padureanu","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106377_bib0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.116.237503","article-title":"Oxidative stress and the central nervous system","volume":"360","author":"Salim","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clineuro.2020.106377_bib0160","first-page":"2016","article-title":"New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis","author":"Adamczyk","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.clineuro.2020.106377_bib0165","first-page":"2015","article-title":"Inflammation, iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis","author":"Haider","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"43","key":"10.1016\/j.clineuro.2020.106377_bib0170","first-page":"2881","article-title":"Inhibitory effect of betulinic acid and 3\u03b2-acetoxybetulinic acid on rat platelet aggregation","volume":"7","author":"Habila","year":"2013","journal-title":"Afr. J. Pharm. Pharmacol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720307204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720307204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:33:15Z","timestamp":1759588395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720307204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"alternative-id":["S0303846720307204"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106377","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2\u2032-deoxyguanosine in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106377"}}